doc. MUDr. Vladimír Krásnik, PhD.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti: VTC1, VTC2, VTC3, VTC4, VTC5
1. | Opatrilova R, Kubatka P, Caprnda M, Büsselberg D, Krasnik V, Vesely P, Saxena S, Ruia S, Mozos I, Rodrigo L, Kruzliak P, Dos Santos KG. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches. Acta Ophthalmologica 2018 | Q1 | IF 3,153 |
2. | Opatrilova R, Caprnda M, Kubatka P, Valentova V, Uramova S, Nosal V, Gaspar L, Zachar L, Mozos I, Petrovic D, Dragasek J, Filipova S, Büsselberg D, Zulli A, Rodrigo L, Kruzliak P, Krasnik V. Adipokines in neurovascular diseases. Biomedicine & Pharmacotherapy. 2018 | Q1 | IF 3,743 |
3. | Saxena S, Caprnda M, Ruia S, Prasad S, Ankita, Fedotova J, Kruzliak P, Krasnik V. Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy. Endocrine. 2019 | Q3 | IF 3,235 |
4. | Caprnda M, Zulli A, Shiwani HA, Kubatka P, Filipova S, Valentova V, Gazdikova K, Mozos I, Berukstis A, Laucevicius A, Rihacek I, Dragasek J, Prosecky R, Egom EE, Staffa R, Kruzliak P, Krasnik V. The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure. Clinical and Experimental Pharmacology and Physiology. 2020 | Q3 | IF 2,557 |
5. | Popov I, Popova V, Krasnik V. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome. Medicina (Kaunas). 2021 | Q2 | IF 2,430 |